Inventor
BREIJ ESTHER C W
NL13 patents
Patents
13 patentsUS11608383B2Mar 21, 2023
Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
GENMAB AS8 citations83
US11535679B2Dec 27, 2022
Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphoma
GENMAB AS8 citations83
US11845805B2Dec 19, 2023
Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphoma
GENMAB AS5 citations72
US11130819B2Sep 28, 2021
Antibodies
GENMAB AS1 citations70
US11008399B2May 18, 2021
Antibodies
GENMAB AS2 citations70
US11858995B2Jan 2, 2024
Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemia
GENMAB AS4 citations69
US11970544B2Apr 30, 2024
Antibodies
GENMAB AS0 citations59
US11814437B2Nov 14, 2023
Antibodies binding to CD30 and CD3
GENMAB AS0 citations57
US11261254B1Mar 1, 2022
Antibodies
GENMAB AS0 citations55
US12246025B2Mar 11, 2025
Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugate
GENMAB AS0 citations54
US12410258B2Sep 9, 2025
Antibodies capable of binding to OX40, variants thereof and uses thereof
GENMAB AS0 citations53
US12453781B2Oct 28, 2025
Methods of treating cancer with a combination of an anti-VEGF antibody and an anti-tissue factor antibody-drug conjugate
GENMAB AS0 citations43
US12324841B2Jun 10, 2025
Methods of treating cancer with a combination of an anti-PD-1 antibody and an anti-tissue factor antibody-drug conjugate
GENMAB AS0 citations43